CellCelector - Single Cell, Colony or Organoid Selection and Retrieval’s Post

As simple as 1 - 2 - 3! What a great new tool.

Exciting News for Cell Researchers! - Sartorius just introduced the #CellCelector Configuration Tool 👇 Whether you're working on #singlecell isolation, #colonypicking, or any other #cellbased application – its your ultimate companion to select the right components building a custom platform which suits your individual #research needs. Try It Today!

Did you know that the therapeutic potential of Exosomes is directly linked to their source? 🧬 𝐖𝐡𝐚𝐭 𝐃𝐨𝐞𝐬 𝐓𝐡𝐢𝐬 𝐌𝐞𝐚𝐧? The cell type and condition producing the exosomes influence their: - Surface components - Internal cargo (proteins, RNA, etc.) 𝐖𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬?  Exosomes reflect the traits of their parent cells, making them ideal for targeted, personalized treatments. Exosomes from specific cells, like stem cells or platelets, are designed for more precise and effective therapies tailored to each patient. Check out the evidence in our new e-book, 𝐁𝐫𝐢𝐝𝐠𝐢𝐧𝐠 𝐭𝐡𝐞 𝐄𝐱𝐨𝐬𝐨𝐦𝐞 𝐆𝐚𝐩: 𝐓𝐚𝐜𝐤𝐥𝐢𝐧𝐠 𝐂𝐮𝐫𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬'📚—a comprehensive resource developed by our scientists and physicians, addressing the current challenges in the exosome market and advancing safer, more effective treatments. Meta Cell Technology🧬 — Breaking the limits of PRP and Autologous Exosomes. 📩 info@metacelltech.com 🔗 www.metacelltech.com #AdvancingTogether with #MCTSystem 💙 #ExosomeTherapy #AutologousExosomes #BiologicalSafety #RegenerativeMedicine #MCTkit #MCTechnology

Enhancing cell therapy by selecting cells with high extracellular vesicle secretion: Ke Cheng at Columbia University, Dino Di Carlo at UCLA and collaborators utilized nanovial technology to enrich millions of single cells based on EV secretion, applying this approach to select mesenchymal stem cells with high EV secretion for improved therapeutic treatment https://lnkd.in/gGt2FTNP They found that the selected MSCs exhibited distinct transcriptional profiles linked to EV biogenesis and vascular regeneration, and maintained high levels of EV secretion after sorting and regrowth. An article also authored by Doyeon Felis Koo, Xiao Cheng, Shreya Udani, SEVANA BAGHDASARIAN, Dashuai Zhu, Junlang Li, Brian Hall, Natalie Tsubamoto, Shiqi Hu and Jina Ko #extracellularvesicles #exosomes #MSCs #flowcytometry #bioengineering #Vesiculab

⏰ Join us Wednesday (9/18) at 11:00 (EDT) for a webinar showcasing a scalable manufacturing platform for the purification of stem cell-derived exosomes. Register here➡ https://lnkd.in/eh8aF7tS #Exosomes represent an emerging therapeutic modality with the ability to target a broad spectrum of clinical indications. To realize this potential, challenges impacting clinical manufacturing must be addressed, including the purification of exosomes at scale. That's why RoosterBio and Cytiva collaborated to characterize a scalable exosome #bioprocessing platform, designed to deliver high yields and purity at clinically relevant scales. #extracellularvesicles #advancedtherapy #cellandgenetherapy #regenerativemedicine #stemcells #biomanufacturing

Stem cells: What are they and why are they important? Watch our video for an easy-to-understand breakdown! We created this video nearly 10 years ago and we are so excited about the progress made since then to advance this promising therapy. For example, clinical trials involving stem cells have skyrocketed from 1,190 (2010-2020) to 6,205 as of today. #StemCells #RegenerativeMedicine #MedicalResearch #ScienceEducation #BioTech #CellTherapy #HealthInnovation #FutureOfMedicine #StemCellResearch #MedicalBreakthroughs

A comprehensive SlideShare presentation on "Stem Cell Therapy" highlighting its revolutionary role in regenerative medicine. It covers the science behind stem cells, their types, clinical applications, and ethical considerations. The presentation also explores emerging advancements and future potential, supported by engaging visuals and concise, easy-to-understand content. #StemCellTherapy #RegenerativeMedicine #MedicalInnovation #Healthcare #Biotechnology #FutureOfMedicine #EthicsInMedicine #ClinicalResearch #StemCells #MedicalAdvancements

A: The project aims to increase the availability of hematopoietic stem cells (HSCs) and progenitor cells (HPCs) through ex vivo culture methods, allowing a single donor to potentially support multiple recipients. Small molecules will be screened to promote HSC self-renewal while preserving their stemness. Additionally, a BioBank of in vitro expanded HSCs will be created for immediate, cryogenically stored access, significantly reducing wait times and improving transplant outcomes for patients. ❓Have questions? Drop them in the comments!❓ #TeamInsightThursday #CellTherapy #StemCells #Innovation #GeneTherapy #CellTherapyOperations #BloodCancers #CellProcessing #Biobank #MobilizedBloodStemCells #Research

The Elves of Innovation Introduce… Cord Blood CD34+ Cells! ✨    What makes these cells extraordinary?   Cord Blood CD34+ cells are self-renewing, multipotent stem cells, the cornerstone of hematopoiesis—the process that produces all blood cells of the immune system. From these stem cells arise:   ✨Myeloid lineage: Monocytes, macrophages, granulocytes, megakaryocytes, dendritic cells, and erythrocytes.   ✨ Lymphoid lineage: T cells, B cells, and NK cells.   These specialized cells work tirelessly, like our elves, to defend the body against infection and disease.     𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐂𝐆𝐓 𝐆𝐥𝐨𝐛𝐚𝐥 𝐨𝐟𝐟𝐞𝐫? ✔️ 𝐂𝐨𝐫𝐝 𝐁𝐥𝐨𝐨𝐝 𝐂𝐃𝟑𝟒+ 𝐂𝐞𝐥𝐥𝐬: Isolated with precision using immunomagnetic anti-CD34 (clone QBEND10) microbeads from the mononuclear cell fraction.   ✔️ 𝐏𝐚𝐢𝐫𝐞𝐝 𝐂𝐨𝐫𝐝 𝐁𝐥𝐨𝐨𝐝 𝐂𝐃𝟑𝟒- 𝐌𝐍𝐂: Because the magic is in the balance!   ✔️ 𝐒𝐚𝐦𝐞 𝐃𝐚𝐲 𝐈𝐬𝐨𝐥𝐚𝐭𝐢𝐨𝐧𝐬: CGT Global’s medical teams work within hospitals to collect cord blood and allow for isolation within hours ensuring the best quality of cells.  ✔️ 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐀𝐬𝐬𝐮𝐫𝐚𝐧𝐜𝐞𝐬: Low Res HLA typing by flow and LCMV testing on nearly all inventory.   Ready to amplify your research and bring innovation to life? Explore our inventory today!  https://lnkd.in/gbsYkrTB   #StemCells #CordBlood #CD34+ #Hematopoiesis #Innovation #CGTGlobal #Biotech 

Clinical grade iPSCs are the beginning of many regenerative medicine development projects. The choice of the right stem cell provider is key to starting the project. In our recent webinar, Dr Mahendra Rao discussed the factors to consider when considering a GMP iPSC-based therapeutic project. He covered the complete GMP iPSC generation process including the choice of reprogramming method, important factors to consider for QC, sourcing the starting cells, and other significant considerations. Watch the webinar: https://hubs.li/Q02qMQTJ0